Announcement on Holding the Investor Briefing on Terminating Major Asset Restructuring
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Holding the Investor Briefing on Terminating Major Asset Restructuring
Filed with SSE · · 2 pages · Chinese
Release
Zhejiang Huakang Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Huakang Pharmaceutical
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Conducting Commodity Futures, Options, and Foreign Exchange Hedging Business
- Announcement on the Closure of the Special Account for Proceeds from the Initial Public Offering
- Announcement on Completing Share Transfer of Invested Company
- Announcement on Convening the 2025 Semi-annual Performance Briefing
Later from Zhejiang Huakang Pharmaceutical
- Announcement on Interest Payment for "Huakang Convertible Bonds" in 2025
- Announcement on the Self-Inspection Report on Stock Trading Activities of Relevant Parties Involved in the Termination of Issuance of Shares and Payment of Cash to Purchase Assets through Related Party Transactions
- Announcement on Extension of Pledge Repurchase Transactions by Shareholders Holding More Than 5% of Shares
- Indicative Announcement on Reduction of Convertible Corporate Bonds by the Actual Controller and Its Concerted Parties and Change of Equity
- Announcement on Early Repurchase of Stock Pledge Repurchase Transactions by Some Controlling Shareholders and Their Persons Acting in Concert
Follow Zhejiang Huakang Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huakang Pharmaceutical